Lonza | LONN - Stock


Lonza reported CHF1.68B in Stock for its fiscal semester ending in December of 2025.





Stock Change Date
Akzo Nobel EUR 1.61B 80M Mar/2026
Alcon AG USD 2.44B 47M Mar/2026
Almirall EUR 178.13M 1.54M Dec/2025
AstraZeneca USD 6.93B 362M Jun/2026
BASF EUR 12.91B 850M Mar/2026
Bayer EUR 12.01B 321M Mar/2026
Beiersdorf EUR 1.61B 63M Dec/2025
Covestro EUR 2.5B 108M Dec/2025
Demant DKK 2.62B 78M Dec/2025
Fresenius EUR 2.73B 119M Mar/2026
Fresenius Medical Care EUR 2.3B 162.24M Mar/2026
Geberit CHF 359.2M 2.7M Dec/2024
Genmab DKK 21M 8M Mar/2026
Givaudan CHF 1.45B 177M Jun/2024
GlaxoSmithKline GBP 6.16B 233M Mar/2026
GN Store Nord DKK 2.31B 62M Dec/2025
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Johnson Matthey GBP 1.55B 455M Jun/2022
Merck EUR 4.78B 220M Mar/2026
Novartis USD 6.22B 66M Jun/2026
Philips EUR 3.22B 106M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
Sika AG CHF 1.21B 182.5M Dec/2022
Solvay EUR 579M 13M Jun/2026
UCB EUR 1.31B 173M Dec/2024